The FDA is considering a change to reduce how often warnings and health disclaimers appear on dietary supplement labels.

Spectral speech features may serve as noninvasive biomarkers for monitoring attention and executive function in major depressive disorder.

Patients with first-episode MDD showed lower effective and functional connectivity between the anterior cingulate cortex and frontal regions.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

A set of 6 distinct midlife depressive symptoms appear to be associated with an increased risk for dementia later in life.

Children in the smartwatch group had significantly shorter mean tantrum durations of 10.4 vs 22.1 minutes and lower odds of tantrums lasting 15 minutes or more. HealthDay News — A smartwatch system ...

Prescription opioids may provide short-term anxiety relief for patients with chronic pain, especially among patients with cancer.

New research highlights socioeconomic and geographic barriers to telemental health care, despite its rapid expansion during the COVID-19 pandemic.

Infection Control & Hospital Epidemiology recently published new guidance for infection prevention and control in nursing homes.